MARA vs REGN · rev $907.1M vs P/E 14, rev $14.34B
Marathon Digital Holdings Inc (MARA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Marathon Digital Holdings Inc (MARA) is a capital markets company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MARA revenue for 2025-12-31 was $907.1M. Net income was -$1.31B. Revenue was up 38.2% from 2024-12-31 to 2025-12-31. MARA currently screens at market cap $6.22B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MARA currently screens at market cap $6.22B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MARA and REGN stock pages for the full models.
Not investment advice.